MedTrace Logo

The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure

NCT02600078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-08-28

No results posted yet for this study

Summary

With exposure to high altitude some individuals will develop acute mountain sickness (AMS). Current evaluation of AMS can make it difficult to rule out other possible conditions. Evaluation of ataxia, as measured by the performance of a coordinated task, can aide in the correct diagnosis of AMS. The investigators have developed novel finger-tapping tasks on a mobile device to assess both reaction time and accuracy. The proposed research will evaluate the utility of this tool in assessing human acclimatization to hypoxia.

Conditions

Interventions

DEVICE

AMS Monitor App

Participants will complete a novel coordination task performed on an android phone.

OTHER

Lake Louise Score

Participants will complete a questionnaire to assess acclimatization to hypoxia.

OTHER

Balance Error Scoring System

Participants will complete a series of static stance positions to evaluate their ability to maintain balance.

OTHER

Heart Rate & Pulse Oxygen Saturation

Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.

Sponsors & Collaborators

  • British Columbia Sports Medicine Research Foundation

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Michael S Koehle, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-03-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02600078 on ClinicalTrials.gov